IRIS
CELLERINO, MARIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 1.956
Totale 1.956
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 1.956
Totale 1.956
Salva come PNG Salva come JPEG
Città #
Genova 911
Genoa 642
Rapallo 389
Bordighera 11
Vado Ligure 3
Totale 1.956
Salva come PNG Salva come JPEG
Nome #
Retinal degeneration in primary-progressive multiple sclerosis: A role for cortical lesions? 129
Different MRI patterns in MS worsening after stopping fingolimod 129
Osteopathic Manipulative Therapy and Multiple Sclerosis: A Proof-of-Concept Study 125
Levodopa-induced neutropenia. 123
Relationship between retinal inner nuclear layer, age, and disease activity in progressive MS 115
Treatment of multiple sclerosis with rituximab: A multicentric Italian-Swiss experience 104
A novel prion protein gene-truncating mutation causing autonomic neuropathy and diarrhea 100
Homonymous hemianopia as the first sign of posterior cortical atrophy 87
Pediatric optic neuritis and anti MOG antibodies: a cohort of Italian patients 69
Impact of treatment on cellular immunophenotype in MS: A cross-sectional study 65
Neuroaxonal Degeneration in Patients With Multiple Sclerosis: An Optical Coherence Tomography and in Vivo Corneal Confocal Microscopy Study 59
Assessing upper limb function in Multiple Sclerosis by an engineered glove 59
Corneal epithelial dendritic cells in patients with multiple sclerosis: An in vivo confocal microscopy study 58
Fingolimod and Dimethyl-Fumarate-Derived Lymphopenia is not Associated with Short-Term Treatment Response and Risk of Infections in a Real-Life MS Population 56
COVID-19 pandemic and mental distress in Multiple Sclerosis: implications for clinical management 54
Severe disease activity in MS patients treated with cladribine after fingolimod withdrawal 53
Corneal sub-basal nerve plexus analysis in patients with multiple sclerosis 48
Tailoring B cell depletion therapy in MS according to memory B cell monitoring 41
Anti-SARS-CoV-2 monoclonal antibodies for the treatment of active COVID-19 in multiple sclerosis: An observational study 39
Choroidal Thickness in Multiple Sclerosis: An Optical Coherence Tomography Study 38
Predictors of Ocrelizumab Effectiveness in Patients with Multiple Sclerosis 34
Relationship Between Retinal Layer Thickness and Disability Worsening in Relapsing-Remitting and Progressive Multiple Sclerosis 34
In-vivo characterization of macro- and microstructural injury of the subventricular zone in relapsing-remitting and progressive multiple sclerosis 33
Influence of Previous Disease-Modifying Drug Exposure on T-Lymphocyte Dynamic in Patients With Multiple Sclerosis Treated With Ocrelizumab 33
CD19+ B cell values predict the increase of anti-SARS CoV2 antibodies in fingolimod-treated and COVID-19-vaccinated patients with multiple sclerosis 28
Risk of Persistent Disability in Patients with Pediatric-Onset Multiple Sclerosis 26
Personalizing ocrelizumab treatment in Multiple Sclerosis: What can we learn from Sars-Cov2 pandemic? 25
Embracing resilience in multiple sclerosis: a new perspective from COVID-19 pandemic 25
What happens after fingolimod discontinuation? A multicentre real-life experience 23
Risk of multiple sclerosis relapses when switching from fingolimod to cell-depleting agents: the role of washout duration 23
Clinical and radiological correlates of apathy in multiple sclerosis 22
Central vein sign and diffusion MRI differentiate microstructural features within white matter lesions of multiple sclerosis patients with comorbidities 20
The role of disconnection in explaining disability in multiple sclerosis 20
Evaluating the central vein sign in paediatric-onset multiple sclerosis: A case series study 20
Physical exercise moderates the effects of disability on depression in people with multiple sclerosis during the covid-19 outbreak 18
Exposure to natalizumab throughout pregnancy: effectiveness and safety in an Italian cohort of women with multiple sclerosis 17
The early effect of cladribrine versus fingolimod on clinical and MRI measures in relapsing remitting multiple sclerosis 15
Multiscale networks in multiple sclerosis 12
Vaccinations in patients with multiple sclerosis: a real-world, single-center experience 12
Is It Time for Ocrelizumab Extended Interval Dosing in Relapsing Remitting MS? Evidence from An Italian Multicenter Experience During the COVID-19 Pandemic 10
EXPLORING THE INTERACTION BETWEEN FOCAL INFLAMMATION AND AXONAL INJURY IN MULTIPLE SCELROSIS: A NEW MECHANISM-DRIVEN FRAMEWORK TO MONITOR DISEASE ACTIVITY AND PROGRESSION 10
Erratum: Choroidal Thickness in Multiple Sclerosis: An Optical Coherence Tomography Study 9
Predicting disease severity in Multiple Sclerosis using multimodal data and machine learning 8
Cognitive rehabilitation and aerobic exercise for cognitive impairment in people with progressive multiple sclerosis (CogEx): a randomised, blinded, sham-controlled trial 7
The effect of Cladribine and Fingolimod treatments on retinal atrophy 6
Effect of ocrelizumab treatment on retinal atrophy: preliminary results from a single-center observational study 6
Vaccinations in patients with multiple sclerosis: a real-world, single-center, experience 6
Totale 2.053
Salva come PNG Salva come JPEG
Categoria #
all - tutte 9.973
article - articoli 9.653
book - libri 0
conference - conferenze 275
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.901
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020394 21 6 10 31 41 53 56 36 44 51 34 11
2020/2021229 11 15 23 36 24 20 11 18 18 36 7 10
2021/2022253 9 4 5 21 13 19 4 55 24 41 9 49
2022/2023469 34 44 11 51 52 62 4 33 77 4 77 20
2023/2024556 20 42 16 58 34 66 156 24 24 26 30 60
2024/202548 48 0 0 0 0 0 0 0 0 0 0 0
Totale 2.053